GLOBAL LYME ALLIANCE INC
Programs
Global Lyme Alliance Research and Support
GLOBAL LYME ALLIANCE (GLA) HAS A STRONG TRACK RECORD OF PROGRAM SERVICE ACCOMPLISHMENTS IN THREE MAJOR AREAS, MEASURED BY EXPENSES: RESEARCH ADVANCEMENTS: GLA INVESTS IN RESEARCH, DRIVING SIGNIFICANT PROGRESS IN LYME AND TICK-BORNE DISEASE STUDIES. THEIR CONTRIBUTIONS INCLUDE GROUNDBREAKING WORK IN DIAGNOSTICS, TREATMENT, AND UNDERSTANDING OF LYME BACTERIA. NOTABLE ACHIEVEMENTS COMPRISE CHARACTERIZING CHRONIC LYME DISEASE, GENOME SEQUENCING OF BORRELIA BURGDORFERI STRAINS, UNCOVERING ANTIBIOTIC RESISTANCE MECHANISMS, AND DOCUMENTING IMMUNE DYSFUNCTION IN PATIENTS. RECENT DISCOVERIES INCLUDE THE ROLE OF CELL WALL-DEFICIENT FORMS (L-FORMS) IN CHRONIC INFECTIONS, POTENTIALLY AIDING EARLY LYME DISEASE CURE.PATIENT SUPPORT: GLA IS COMMITTED TO AIDING PATIENTS, CAREGIVERS, AND LOVED ONES AFFECTED BY THESE DISEASES. THEY OFFER VARIOUS SUPPORT PROGRAMS, SUCH AS ACCESS TO SPECIALISTS, FINANCIAL ASSISTANCE INFORMATION, CLINICAL TRIAL OPPORTUNITIES, EMOTIONAL SUPPORT MENTORSHIP, AND EDUCATIONAL MATERIALS. THEIR HOLISTIC APPROACH ADDRESSES PATIENTS AND FAMILIES' CHALLENGES COMPREHENSIVELY.KNOWLEDGE AND AWARENESS: GLA'S RESEARCH AND EDUCATIONAL INITIATIVES HAVE PLAYED A PIVOTAL ROLE IN ENHANCING UNDERSTANDING AND AWARENESS OF LYME AND TICK-BORNE DISEASES. THEIR FUNDING OF STUDIES CONNECTING LYME DISEASE TO PSYCHIATRIC DISORDERS HAS BROADENED AWARENESS OF THE DISEASES' IMPACT ON PATIENTS' WELL-BEING. MOREOVER, GLA'S DEDICATION TO SHARING EDUCATIONAL RESOURCES AND CLINICAL TRIAL INFORMATION EMPOWERS THE COMMUNITY TO MAKE INFORMED HEALTH DECISIONS.GeographiesNot indicatedDatesJan 1, 2022 – Dec 31, 2022Source990No causes providedNo populations provided–$1MLyme Disease Research Grant Program
GLOBAL LYME ALLIANCE CONTINUES TO ADVANCE THE RESEARCH AND SCIENCE FOR LYME AND OTHER TICK-BORNE DISEASES THROUGH ITS ROBUST RESEARCH GRANT PROGRAM. GLA'S SCIENTIFIC ADVISORY BOARD (SAB), COMPRISED OF DISTINGUISHED RESEARCHERS IN MULTIDISCIPLINARY FIELDS IN LYME AND TICK-BORNE DISEASE, PROVIDES STRATEGIC GUIDANCE TO GLOBAL LYME ALLIANCE IN ITS REVIEW AND AWARD PROCESS TO ADVANCE RESEARCH AT LEADING INSTITUTIONS WITH A GOAL OF IMPROVING DIAGNOSTICS AND TREATMENT OF LYME AND OTHER TICK-BORNE ILLNESSES.AS THE LEADING PATIENT VOICE LYME NON-PROFIT MEASURED BY OUR AUDIENCE SHARE, GLA GETS INPUT FROM OUR MEDICAL ADVISORY BOARD AND PATIENT ADVOCATES TO DRIVE RESEARCH DISCOVERY; GLA BRIDGES THE GAP BETWEEN PATIENT AND RESEARCH TO INFORM WHERE SCIENCE NEEDS TO GO TO FIND A CURE.GeographiesNot indicatedDatesJan 1, 2022 – Dec 31, 2022Source990No causes providedNo populations provided–$872.9K
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)